>Go!
NEWS SEARCH

05.22.2009 | Investors

Watson to Present at the Sanford C. Bernstein & Co. Twenty-Fifth Annual Strategic Decisions 2009 Conference

CORONA, CA, May 22, 2009 (MARKETWIRE via COMTEX) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Sanford C. Bernstein & Co. Twenty-Fifth Annual Strategic Decisions 2009 Conference on Wednesday, May 27, 2009 at 9:00 a.m. Eastern Daylight Time.

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL:

http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=WPI&item_id=2184558

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

CONTACT:
Watson Pharmaceuticals, Inc.
Patty Eisenhaur
(951) 493-5611

SOURCE: Watson Pharmaceuticals





                    
Media Contacts
Mark Marmur
Global Corporate Media Relations
+1 (862) 261 7558
Fran DeSena
U.S. Product Media Relations
+1 (201) 427-8762
Janet Kettels
International Product Media Relations
+44 773 850 6476

For local media contacts in other countries, please visit the relevant country website.

Investor relations:

Karina Calzadilla
Investor Relations
+1 (862) 261 7488